Anxiety Disorders

Pregnancy and the puerperium are associated with high vulnerability to mental illnesses. Anxiety disorders, which have not been extensively studied, are common during the perinatal period, and their actual prevalence is probably underestimated. Studies on the pharmacological effects of drugs during pregnancy are inconclusive, and further research is needed to devise clear guidance. Overall, psychotherapeutic treatment should be the first choice for mild anxious symptoms, whereas drugs should be considered for moderate-to-severe anxiety. “No treatment” is not a valid alternative because of the well-documented medical and psychological consequences of untreated maternal anxiety on newborns. Therefore, identifying perinatal anxiety disorders is crucial for providing valid treatment options to the future mother and preventing any consequences for the child.